首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi

市場調查報告書

商品編碼

1918128

蛋白質表現市場－2026-2031年預測

Protein Expression Market - Forecast from 2026 to 2031

出版日期: 2026年01月15日 | 出版商:

Knowledge Sourcing Intelligence | 英文 149 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計蛋白質表現市場將從 2025 年的 37.68 億美元成長到 2031 年的 58.52 億美元，複合年成長率達到 7.61%。

蛋白質表現市場正經歷強勁成長，這主要得益於技術創新、生物製藥產業的擴張以及研發能力的提升。蛋白質表現是將遺傳訊息轉化為執行細胞功能的功能性蛋白質的過程，是現代生物技術和藥物研發的核心技術。基因工程和蛋白質組學的進步，以及生物製藥行業的蓬勃發展和對罕見疾病日益成長的關注，都在推動市場的發展。

市場主要促進因素

基因工程的進展

基因工程技術的進步，特別是CRISPR-Cas9技術的進步，顯著提升了我們設計細胞株係以提高蛋白質表現的能力。 CRISPR-Cas9基因編輯平台能夠精確且有效率地編輯特定的DNA序列，簡化了在不同生物體中基因的添加、刪除或修飾。這些技術優勢是蛋白質表現市場成長要素。

2023年1月，Kytopean公司啟動了其基因遞送平台Flowfect Discover的早期使用計劃，旨在提高複雜基因工程材料的遞送精度和效率。這正是新興平台如何推動蛋白質表現能力提升的典型例子。此外，DNA合成技術的進步使得客製化DNA序列的建構更加便利、成本更低，從而普及了先進的基因工程工具，並擴大了蛋白質表現技術的潛在用戶群。

生物製藥產業的擴張

生技產業的蓬勃發展以及製藥公司對生物製藥的日益重視，正積極推動蛋白質表現市場的發展。包括基因工程、重組DNA技術和蛋白質表現系統在內的生物技術的快速發展，使得新型生物製藥的生產成為可能。策略聯盟的建立正在拓展生物製藥領域，並促進蛋白質表現市場的成長。 2022年9月，CytoReason與輝瑞公司簽署了一份為期五年的合作協議延期文件，旨在利用人工智慧技術進行藥物發現和開發舉措。這正是夥伴關係如何加速生物製藥創新以及相關蛋白質表現需求的例子。

關注罕見疾病

製藥業日益重視罕見疾病孤兒藥的研發，這為蛋白質表現市場創造了巨大的機會。許多孤兒藥都是基於蛋白質的治療方法，需要特定的蛋白質分子，這直接推動了對蛋白質表現技術的需求。大約有3000萬美國人患有罕見疾病，這表明存在巨大的未滿足醫療需求。美國國立衛生研究院（NIH）的罕見疾病臨床研究網路計畫等措施支持了這種對罕見疾病治療日益成長的關注，該計畫透過促進研究人員之間的合作、增加研究參與度和推動數據共用來加速醫學研究。

蛋白質體學進展

蛋白質體學的進步從根本上改變了我們對蛋白質及其生物學功能的理解，並推動了蛋白質表現市場的發展。現代質譜技術，包括串聯式質譜質譜和液相層析-質譜聯用技術，實現了靈敏且高通量的蛋白質分析。結構測定方法，例如X光晶體衍射、核磁共振波譜和冷凍電鏡，使研究人員能夠以高解析度解析蛋白質結構，從而揭示蛋白質相互作用和機制的重要資訊。

此外，將蛋白質體學與基因組學和轉錄組學數據整合，能夠對細胞過程進行全面分析。多體學方法提供了生物系統內基因表現調控和分子相互作用的整體情況，拓展了我們的研究能力，並催生了對先進蛋白質表現平台的需求，以支持這些整合的分析工作流程。

市場限制

儘管蛋白質表現市場成長勢頭強勁，但仍面臨一些阻礙其擴張的挑戰。蛋白質表現系統的建構和維護成本高昂，高額的初始投資可能會使小規模的研究機構和預算有限的公司難以採用這項技術。技術限制也是一大障礙：需要大量轉譯後修飾的真核蛋白可能無法在原核生物系統（例如細菌）中有效表達或加工，因此需要更複雜、更耗時的真核表達平台。

此外，蛋白質表現市場競爭異常激烈，許多現有企業爭奪市場佔有率，新進入者難以立足。在這種競爭環境下，企業需要不斷創新和差異化才能維持市場地位。

區域和近期趨勢

由於北美擁有強大的醫療保健基礎設施、不斷成長的醫療保健研發投入、蛋白質技術的應用日益廣泛以及慢性病負擔日益加重，預計北美在預測期內將保持顯著的市場佔有率。與其他高所得國家相比，美國的醫療保健支出仍然顯著較高，無論從人均支出還是佔GDP的百分比來看都是如此。不斷擴張的製藥業進一步推動了區域市場的成長，製藥業對國民經濟的貢獻也顯著增加。

近期市場趨勢凸顯了持續創新的重要性。 2023年7月，Lonza推出了TheraPRO® CHO培養基系統，該系統與GS-CHO細胞株配合使用時，可最佳化生產效率和蛋白質質量，從而幫助製藥和生物技術公司生產治療性蛋白質。 2023年5月，10x Genomics推出了Visium CytAssist基因和蛋白質表現分析試劑盒，擴展了其空間分析能力，並增強了其對基因和蛋白質表現模式的研究範圍。

受技術進步、治療方法創新以及生物技術和製藥領域研究應用不斷擴展的推動，蛋白質表現市場持續發展。

本報告的主要優勢：

深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略實現市場滲透的潛力。
市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

歷史資料（2021-2025 年）和預測資料（2026-2031 年）
成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
競爭對手定位、策略和市場佔有率分析
按業務板塊和地區（國家）分類的收入成長和預測分析
公司概況（策略、產品、財務資訊、關鍵趨勢等）

The protein expression market is experiencing robust growth driven by technological innovation, biopharmaceutical expansion, and evolving research capabilities. Protein expression-the process by which genetic information is converted into functional proteins that carry out cellular functions-has become central to modern biotechnology and drug development. Advancements in genetic engineering and proteomics, combined with the expanding biopharmaceutical industry and increasing focus on rare diseases, are propelling market momentum.

Core Market Drivers

Genetic Engineering Advancements

Progress in genetic engineering techniques, particularly CRISPR-Cas9 technology, has substantially enhanced the ability to engineer cell lines for improved protein expression. The CRISPR-Cas9 gene editing platform enables precise and efficient editing of specific DNA sequences, simplifying the addition, deletion, or modification of genes across diverse organisms. These technological capabilities represent major growth drivers for the protein expression market.

In January 2023, Kytopean launched an early access program for its gene delivery platform 'Flowfect Discover,' enabling delivery of complex genetic engineering materials with enhanced precision and efficiency. This exemplifies how emerging platforms are advancing protein expression capabilities. Additionally, advances in DNA synthesis technologies have made custom DNA sequence creation easier and more affordable, democratizing access to sophisticated genetic engineering tools and expanding the potential user base for protein expression technologies.

Biopharmaceutical Industry Expansion

The biotechnology industry's growth and pharmaceutical companies' increasing biologics adoption have positively contributed to protein expression market development. Rapid developments in biotechnology-including genetic engineering, recombinant DNA technology, and protein expression systems-have enabled novel biopharmaceutical production. Strategic collaborations are expanding the biopharmaceutical landscape and supporting protein expression market growth. In September 2022, CytoReason and Pfizer entered an extended five-year collaboration agreement to utilize artificial intelligence in drug discovery and development initiatives, demonstrating how partnerships are accelerating biopharmaceutical innovation and associated protein expression demands.

Rare Disease Focus

The pharmaceutical industry has emphasized orphan medication development for rare diseases, creating significant opportunities for the protein expression market. Many orphan medications are protein-based therapies requiring specialized protein molecules, directly driving demand for protein expression technologies. Approximately 30 million Americans are impacted by rare diseases, highlighting substantial unmet medical needs. The growing treatment focus is evidenced by initiatives like the NIH's Rare Diseases Clinical Research Network program, which accelerates medical research by promoting collaboration, facilitating study enrollment, and fostering data sharing among researchers.

Proteomics Advances

Progress in proteomics has fundamentally transformed understanding of proteins and their biological roles, propelling the protein expression market. Modern mass spectrometry techniques-including tandem mass spectrometry and liquid chromatography-mass spectrometry-enable sensitive, high-throughput protein analysis. Structural determination methods like X-ray crystallography, nuclear magnetic resonance spectroscopy, and cryo-electron microscopy allow researchers to determine protein structures at high resolutions, revealing critical insights into protein interactions and mechanisms.

Furthermore, integrating proteomics with genomics and transcriptomics data enables comprehensive cellular process analyses. Multi-omics approaches provide holistic views of gene expression regulation and molecular interactions within biological systems, expanding research capabilities and creating demand for sophisticated protein expression platforms that support these integrated analytical workflows.

Market Constraints

Despite positive growth trajectories, the protein expression market faces challenges impacting expansion. Establishing and maintaining protein expression systems can be expensive, with high initial investments potentially deterring smaller research organizations or budget-constrained companies from adopting these technologies. Technical limitations also present obstacles: eukaryotic proteins requiring extensive post-translational modifications may not be adequately expressed or processed in prokaryotic systems like bacteria, necessitating more complex and time-consuming eukaryotic expression platforms.

Additionally, the protein expression market experiences intense competition, with numerous established companies competing for market share, making market entry challenging for new participants. This competitive landscape requires continuous innovation and differentiation to maintain market position.

Regional Dynamics and Recent Developments

North America is expected to hold significant market share during the forecast period, supported by strong healthcare infrastructure, increasing healthcare R&D investment, growing protein technology usage, and rising chronic disease burden. Healthcare spending in the United States remains substantially higher-both per capita and as GDP percentage-compared to other high-income nations. The expanding pharmaceutical industry further augments regional market growth, with pharmaceutical sector contributions to national economies increasing significantly.

Recent market developments underscore ongoing innovation. In July 2023, Lonza launched the TheraPRO(R) CHO Media System to optimize productivity and protein quality when used with GS-CHO cell lines, supporting pharmaceutical and biotechnology companies manufacturing therapeutic proteins. In May 2023, 10x Genomics introduced the Visium CytAssist Gene and Protein Expression Assay to broaden spatial analysis capabilities, enhancing the scope of gene and protein expression pattern studies.

The protein expression market continues evolving, driven by technological sophistication, therapeutic innovation, and expanding research applications across biotechnology and pharmaceutical sectors.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2021 to 2025 & forecast data from 2026 to 2031
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Protein Expression Market Segmentation

By Expression System
Prokaryotic
Mammalian Cell
Insect Cell
Yeast
Others
By Application
Therapeutic
Industrial
Research
By Product
Reagents
Competent Cells
Expression Vectors
Services
Instruments
By Geography
North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. PROTEIN EXPRESSION MARKET BY EXPRESSION SYSTEM

5.1. Introduction
5.2. Prokaryotic
5.3. Mammalian Cell
5.4. Insect Cell
5.5. Yeast
5.6. Others

6. PROTEIN EXPRESSION MARKET BY APPLICATION

6.1. Introduction
6.2. Therapeutic
6.3. Industrial
6.4. Research

7. PROTEIN EXPRESSION MARKET BY PRODUCT

7.1. Introduction
7.2. Reagents
7.3. Competent Cells
7.4. Expression Vectors
7.5. Services
7.6. Instruments

8. PROTEIN EXPRESSION MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. USA
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. Germany
- 8.4.2. France
- 8.4.3. United Kingdom
- 8.4.4. Spain
- 8.4.5. Others
8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Others
8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others